Literature DB >> 18021989

Ischemic cholangiopathy after liver transplantation from controlled non-heart-beating donors-a single-center experience.

B Kaczmarek1, M D Manas, B C Jaques, D Talbot.   

Abstract

BACKGROUND: Previous reports have shown that livers from controlled non-heart-beating-donors (NHBD) are associated with higher rates of primary failure and ischemic cholangiopathy of orthotopic liver transplantation (OLT) as a complication of the prolonged warm ischemia.
METHODS: This retrospective review of activities from 1999 to 2006 examined donor characteristics of age, liver function tests, warm ischemic time before (1WITa) and after cardiac arrest (1WITb), cold ischemic time (CIT) and transplant results.
RESULTS: Eleven NHBD retrieved livers were transplanted from "ideal" donors except for one elderly donor (73 years). Of the 11 recipients, 3 developed biliary cholangiopathy (27%). There were no episodes of primary graft nonfunction, but one recipient displayed primary graft dysfunction. Two recipients died: one due to biliary complications with sepsis (long CIT >10 hours, fatty liver), and the other due to aspiration pneumonia and hypoxic brain damage with normal liver function. One recipient required retransplantation owing to ischemic cholangiopathy (1WITb 45 min) at 6 months after OLT with a good result. The other eight recipients are alive (observation period 72 to 14 months) including six with normal liver function, one with biopsy-proven biliary ischemia and one with recurrent primary sclerosing cholangitis without biliary ischemic changes on biopsy. Among 164 heart-beating donors recipients transplanted in the same period, biliary complications occurred in 27 patients (16%), of whom 12 were leaks and 15 anastomotic strictures.
CONCLUSION: NHBD were a good source for livers with reasonable early results. To avoid late complications especially ischemic cholangiopathy, caution is urged with the use of these organs as well as strict donor and ischemic time criteria.

Entities:  

Mesh:

Year:  2007        PMID: 18021989     DOI: 10.1016/j.transproceed.2007.08.081

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  9 in total

1.  Preservation of non-heart-beating donor livers in extracorporeal liver perfusion and histidine-trytophan-ketoglutarate solution.

Authors:  Jin Gong; Xue-Jun Lao; Xi-Mo Wang; Gang Long; Tao Jiang; Shi Chen
Journal:  World J Gastroenterol       Date:  2008-04-21       Impact factor: 5.742

2.  Biliary complications after liver transplantation from donation after cardiac death donors: an analysis of risk factors and long-term outcomes from a single center.

Authors:  David P Foley; Luis A Fernandez; Glen Leverson; Michael Anderson; Joshua Mezrich; Hans W Sollinger; Anthony D'Alessandro
Journal:  Ann Surg       Date:  2011-04       Impact factor: 12.969

Review 3.  Role of matrix metalloproteinases in cholestasis and hepatic ischemia/reperfusion injury: A review.

Authors:  Giuseppina Palladini; Andrea Ferrigno; Plinio Richelmi; Stefano Perlini; Mariapia Vairetti
Journal:  World J Gastroenterol       Date:  2015-11-14       Impact factor: 5.742

4.  Donation after cardio-circulatory death liver transplantation.

Authors:  Hieu Le Dinh; Arnaud de Roover; Abdour Kaba; Séverine Lauwick; Jean Joris; Jean Delwaide; Pierre Honoré; Michel Meurisse; Olivier Detry
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

5.  The impact of ischemic cholangiopathy in liver transplantation using donors after cardiac death: the untold story.

Authors:  Anton I Skaro; Colleen L Jay; Talia B Baker; Edward Wang; Sarina Pasricha; Vadim Lyuksemburg; John A Martin; Joseph M Feinglass; Luke B Preczewski; Michael M Abecassis
Journal:  Surgery       Date:  2009-10       Impact factor: 3.982

6.  Metabotropic Glutamate Receptor Blockade Reduces Preservation Damage in Livers from Donors after Cardiac Death.

Authors:  Laura Giuseppina Di Pasqua; Clarissa Berardo; Marta Cagna; Roberta Verta; Debora Collotta; Ferdinando Nicoletti; Andrea Ferrigno; Massimo Collino; Mariapia Vairetti
Journal:  Int J Mol Sci       Date:  2021-02-24       Impact factor: 5.923

7.  Advantages and Limitations of Clinical Scores for Donation After Circulatory Death Liver Transplantation.

Authors:  Raphael P H Meier; Yvonne Kelly; Seiji Yamaguchi; Hillary J Braun; Tyler Lunow-Luke; Dieter Adelmann; Claus Niemann; Daniel G Maluf; Zachary C Dietch; Peter G Stock; Sang-Mo Kang; Sandy Feng; Andrew M Posselt; James M Gardner; Shareef M Syed; Ryutaro Hirose; Chris E Freise; Nancy L Ascher; John P Roberts; Garrett R Roll
Journal:  Front Surg       Date:  2022-01-05

8.  Sustained Isoprostane E2 Elevation, Inflammation and Fibrosis after Acute Ischaemia-Reperfusion Injury Are Reduced by Pregnane X Receptor Activation.

Authors:  Aimen O Amer; Philip M Probert; Michael Dunn; Margaret Knight; Abigail E Vallance; Paul A Flecknell; Fiona Oakley; Iain Cameron; Steven A White; Peter G Blain; Matthew C Wright
Journal:  PLoS One       Date:  2015-08-24       Impact factor: 3.240

9.  Outcomes of Adult Liver Transplantation from Donation After Brain Death Followed by Circulatory Death in China.

Authors:  Jiabin Zhang; Hui Ren; Yanling Sun; Zhijie Li; Hongbo Wang; Zhenwen Liu; Shaotang Zhou
Journal:  Ann Transplant       Date:  2018-05-01       Impact factor: 1.530

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.